Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution Meeting Abstract
| Authors: | Apolo, A. B.; Ballman, K.; Sonpavde, G. P.; Berg, S.; Kim, W.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D.; Grivas, P.; Chatta, G.; Reichert, Z.; Kim, J. W.; Bilen, M. A.; McGregor, B. A.; Srinivas, S.; Halabi, S.; Perez Burbano, G.; Morris, M. J.; Rosenberg, J. E. |
| Abstract Title: | Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S1135 |
| End Page: | S1136 |
| Language: | English |
| ACCESSION: | WOS:001326612902579 |
| DOI: | 10.1016/j.annonc.2024.08.2049 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1964MO -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work